Indirect comparison of bazedoxifene vs oral bisphosphonates for the prevention of vertebral fractures in postmenopausal osteoporotic women.

@article{Ellis2014IndirectCO,
  title={Indirect comparison of bazedoxifene vs oral bisphosphonates for the prevention of vertebral fractures in postmenopausal osteoporotic women.},
  author={Alexandra G. Ellis and J -Y Reginster and Xuemei Luo and Andrew G. Bushmakin and Robert X Williams and Santosh Sutradhar and Sebasti{\'a}n Mirkin and Jeroen P. Jansen},
  journal={Current medical research and opinion},
  year={2014},
  volume={30 8},
  pages={1617-26}
}
OBJECTIVE Compare the efficacy of bazedoxifene with oral bisphosphonates for reduction of vertebral fracture risk in postmenopausal osteoporotic (PMO) women and in higher-risk patients based on evidence from randomized controlled trials (RCTs). METHODS Eight RCTs assessing vertebral fracture risk reduction with oral bisphosphonates (n = 7) or bazedoxifene (n = 1) were identified by a systematic literature review. Individual study results were pooled in a network meta-analysis (NMA) to… CONTINUE READING
2 Citations
27 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 27 references

Agency

  • EMA European Medicine
  • Assessment Report for Conbriza. Procedure No…
  • 2013

Similar Papers

Loading similar papers…